NEW The November 2026 edition is out — Special Report: India's Specialty Chemicals Decade
  1. Home
  2. Latest News
  3. Pharmaceuticals

API makers expand key starting material capacity to reduce single-source dependence

Producers of antibiotics and cardiovascular APIs are investing upstream into key starting materials and advanced intermediates.

KR
Dr. Kavita Rao
Pharma & Life Sciences Editor · · 2 min read
Illustration of pharmaceutical capsules and molecular structures

Several Indian active pharmaceutical ingredient (API) manufacturers are investing upstream into key starting materials (KSMs) and advanced intermediates, according to investor presentations and plant visits by our sample editorial team. The move is aimed at reducing dependence on single-source imports for critical molecules.

The fictional Sahyadri Life Molecules said it would commission a fermentation-based intermediate block next year, while Deccan API Works is adding a dedicated solvent-recovery unit to improve the economics of a multi-step synthesis.

The cost question

Backward integration rarely pays off on cost alone in the early years. Producers point instead to supply security, regulatory traceability and the ability to win long-term contracts with regulated-market customers who now audit the full supply chain.

Industry associations have urged faster environmental approvals and shared infrastructure, including common effluent treatment and solvent recovery, to help smaller players participate.

Keep reading

More from Latest News

View all